Categories Earnings, Health Care

Novo Nordisk’s (NYSE: NVO) profit declines 3% in Q1 2019

Denmark-based healthcare giant Novo Nordisk (NYSE: NVO, CPH: NOVO-B) reported its first quarter 2019 results today. Novo Nordisk’s profit dropped 3%, while sales increased 9% for the three months ended March 31, 2019. Operating profit grew 8% at constant exchange rates.

Shares of Novo Nordisk, which closed down 0.53% at $48.87 on NYSE, were down about 2% in the pre-market hours. Novo Nordisk stock was trading flat on Copenhagen Stock Exchange at 11:00 AM GMT.

Novo Nordisk 1Q19 earnings - geographical sales

All the regions in the International Operations registered sales growth in both reported and at constant exchange rates. Sales from North America Operations grew 4% on a reported basis, while it declined 4% at constant exchange rates.

Diabetes and Obesity segment sales advanced 10% on a reported basis and 5% at constant exchange rates. Sales from Biopharmaceuticals segment rose 3% on a reported basis and was flat at constant exchange rates.

“We delivered very solid performance in International Operations, driven by sales growth in all regions, meanwhile, sales in the USA were negatively impacted by inventory reductions. The global launch of Ozempic, our new once-weekly GLP-1, is well on track and continues to gain market share,” said CEO Lars Fruergaard Jørgensen.

For 2019, Novo Nordisk expects sales to grow between 2% and 5% and operating profit to increase between 2% and 6%, both at constant exchange rates.

The company stated that pricing pressure within diabetes is expected to conintue, especially in the US. This includes the funding of the Medicare Part D coverage gap, which has been changed based on new legislation with effect from 2019, and with an expected negative impact of approximately DKK 2 billion.

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

PepsiCo (PEP) expects snacks business to remain resilient in the near term

PepsiCo Inc. (NASDAQ: PEP) reported first quarter 2021 earnings results on Thursday that topped expectations on both the top and bottom lines. The stock has gained 7% in the past

For Wells Fargo (WFC), Q1 sets the stage for long-term recovery

Emerging from the slowdown caused by coronavirus, the financial services sector entered fiscal 2021 on a bright note, thanks to improving economic activity and the COVID-driven boom in stock trading.

Top 3 Artificial Intelligence stocks you may consider in 2021

Artificial Intelligence has become an integral part of the US economy. According to the analyst’s insights, AI market revenue in 2020 was $25.9 billion. The AI market in the North

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top